Introduction – Company Background

GuangXin Industrial Co., Ltd. is a specialized manufacturer dedicated to the development and production of high-quality insoles.

With a strong foundation in material science and footwear ergonomics, we serve as a trusted partner for global brands seeking reliable insole solutions that combine comfort, functionality, and design.

With years of experience in insole production and OEM/ODM services, GuangXin has successfully supported a wide range of clients across various industries—including sportswear, health & wellness, orthopedic care, and daily footwear.

From initial prototyping to mass production, we provide comprehensive support tailored to each client’s market and application needs.

At GuangXin, we are committed to quality, innovation, and sustainable development. Every insole we produce reflects our dedication to precision craftsmanship, forward-thinking design, and ESG-driven practices.

By integrating eco-friendly materials, clean production processes, and responsible sourcing, we help our partners meet both market demand and environmental goals.

Core Strengths in Insole Manufacturing

At GuangXin Industrial, our core strength lies in our deep expertise and versatility in insole and pillow manufacturing. We specialize in working with a wide range of materials, including PU (polyurethane), natural latex, and advanced graphene composites, to develop insoles and pillows that meet diverse performance, comfort, and health-support needs.

Whether it's cushioning, support, breathability, or antibacterial function, we tailor material selection to the exact requirements of each project-whether for foot wellness or ergonomic sleep products.

We provide end-to-end manufacturing capabilities under one roof—covering every stage from material sourcing and foaming, to precision molding, lamination, cutting, sewing, and strict quality control. This full-process control not only ensures product consistency and durability, but also allows for faster lead times and better customization flexibility.

With our flexible production capacity, we accommodate both small batch custom orders and high-volume mass production with equal efficiency. Whether you're a startup launching your first insole or pillow line, or a global brand scaling up to meet market demand, GuangXin is equipped to deliver reliable OEM/ODM solutions that grow with your business.

Customization & OEM/ODM Flexibility

GuangXin offers exceptional flexibility in customization and OEM/ODM services, empowering our partners to create insole products that truly align with their brand identity and target market. We develop insoles tailored to specific foot shapes, end-user needs, and regional market preferences, ensuring optimal fit and functionality.

Our team supports comprehensive branding solutions, including logo printing, custom packaging, and product integration support for marketing campaigns. Whether you're launching a new product line or upgrading an existing one, we help your vision come to life with attention to detail and consistent brand presentation.

With fast prototyping services and efficient lead times, GuangXin helps reduce your time-to-market and respond quickly to evolving trends or seasonal demands. From concept to final production, we offer agile support that keeps you ahead of the competition.

Quality Assurance & Certifications

Quality is at the heart of everything we do. GuangXin implements a rigorous quality control system at every stage of production—ensuring that each insole meets the highest standards of consistency, comfort, and durability.

We provide a variety of in-house and third-party testing options, including antibacterial performance, odor control, durability testing, and eco-safety verification, to meet the specific needs of our clients and markets.

Our products are fully compliant with international safety and environmental standards, such as REACH, RoHS, and other applicable export regulations. This ensures seamless entry into global markets while supporting your ESG and product safety commitments.

ESG-Oriented Sustainable Production

At GuangXin Industrial, we are committed to integrating ESG (Environmental, Social, and Governance) values into every step of our manufacturing process. We actively pursue eco-conscious practices by utilizing eco-friendly materials and adopting low-carbon production methods to reduce environmental impact.

To support circular economy goals, we offer recycled and upcycled material options, including innovative applications such as recycled glass and repurposed LCD panel glass. These materials are processed using advanced techniques to retain performance while reducing waste—contributing to a more sustainable supply chain.

We also work closely with our partners to support their ESG compliance and sustainability reporting needs, providing documentation, traceability, and material data upon request. Whether you're aiming to meet corporate sustainability targets or align with global green regulations, GuangXin is your trusted manufacturing ally in building a better, greener future.

Let’s Build Your Next Insole Success Together

Looking for a reliable insole manufacturing partner that understands customization, quality, and flexibility? GuangXin Industrial Co., Ltd. specializes in high-performance insole production, offering tailored solutions for brands across the globe. Whether you're launching a new insole collection or expanding your existing product line, we provide OEM/ODM services built around your unique design and performance goals.

From small-batch custom orders to full-scale mass production, our flexible insole manufacturing capabilities adapt to your business needs. With expertise in PU, latex, and graphene insole materials, we turn ideas into functional, comfortable, and market-ready insoles that deliver value.

Contact us today to discuss your next insole project. Let GuangXin help you create custom insoles that stand out, perform better, and reflect your brand’s commitment to comfort, quality, and sustainability.

🔗 Learn more or get in touch:
🌐 Website: https://www.deryou-tw.com/
📧 Email: shela.a9119@msa.hinet.net
📘 Facebook: facebook.com/deryou.tw
📷 Instagram: instagram.com/deryou.tw

China pillow OEM manufacturer

Are you looking for a trusted and experienced manufacturing partner that can bring your comfort-focused product ideas to life? GuangXin Industrial Co., Ltd. is your ideal OEM/ODM supplier, specializing in insole production, pillow manufacturing, and advanced graphene product design.

With decades of experience in insole OEM/ODM, we provide full-service manufacturing—from PU and latex to cutting-edge graphene-infused insoles—customized to meet your performance, support, and breathability requirements. Our production process is vertically integrated, covering everything from material sourcing and foaming to molding, cutting, and strict quality control.Graphene sheet OEM supplier factory Taiwan

Beyond insoles, GuangXin also offers pillow OEM/ODM services with a focus on ergonomic comfort and functional innovation. Whether you need memory foam, latex, or smart material integration for neck and sleep support, we deliver tailor-made solutions that reflect your brand’s values.

We are especially proud to lead the way in ESG-driven insole development. Through the use of recycled materials—such as repurposed LCD glass—and low-carbon production processes, we help our partners meet sustainability goals without compromising product quality. Our ESG insole solutions are designed not only for comfort but also for compliance with global environmental standards.Graphene insole manufacturing factory in Taiwan

At GuangXin, we don’t just manufacture products—we create long-term value for your brand. Whether you're developing your first product line or scaling up globally, our flexible production capabilities and collaborative approach will help you go further, faster.China OEM factory for footwear and bedding

📩 Contact us today to learn how our insole OEM, pillow ODM, and graphene product design services can elevate your product offering—while aligning with the sustainability expectations of modern consumers.Indonesia insole OEM manufacturer

The new species of lipstick vine, Aeschynanthus pentatrichomatus. Credit: Chris Thorogood. Botanists discovered a new lipstick vine species, Aeschynanthus pentatrichomatus, in the Philippine rainforest. Found during a 2022 expedition, the plant is critically endangered and underscores the need for conservation in biodiversity hotspots. Scientists have announced the discovery of a previously unknown species of lipstick vine, uncovered in the depths of the Philippine rainforest. The groundbreaking findings were published in the Nordic Journal of Botany. A team of botanists from Oxford University and the University of the Philippines Los Baños made the discovery during a 2022 expedition to the remote Barangay Balbalasang rainforest on Luzon Island. Accessing this nearly impenetrable wilderness required several days of travel and the use of machetes to clear a path. During their exploration, the team was hosted by the Banao Tribe, an indigenous community who protect their local forest. A Unique Botanical Discovery Examining the material they collected from the trips, botanists Jayson Mansibang, Adriane Tobias, Pastor Malabrigo Jr (University of the Philippines Los Baños), and Dr. Chris Thorogood (Deputy Director and Head of Science for Oxford Botanic Garden and Arboretum and lecturer at Oxford University’s Department of Biology) realized they had stumbled upon a specimen unlike any related type of lipstick vine known to date. In particular, the plant’s flowers have a distinct pattern of delicate purple mottling, similar to that of a European foxglove. The expedition team, led by a member of the Banao Indigenous Community in a remote rainforest in Kalinga, the Philippines. Credit: Chris Thorogood. Dr. Chris Thorogood said, “We were trekking through dense vegetation when suddenly we spotted a luminous white, purple-spotted flower dangling above our heads. We suspected immediately that it was new to science. It’s so exciting that beautiful species like this are still there waiting to be described.” Together, the scientists named the plant Aeschynanthus pentatrichomatus from the Latin ‘penta’ meaning five and ‘trichomatus’ referring to the trichomes – hair-like outgrowths deep in the throats of the flowers. Lipstick vines (genus Aeschynanthus) comprise around 180 tropical and subtropical species which are named for the tubular appearance of the developing buds as they emerge. They typically grow as vines on other plants and trees, and have brightly coloured flowers that are pollinated by birds. A Call for Conservation The new species has already been assessed as Critically Endangered, since the population is at high risk of total forest destruction due to the growing intensity of typhoons caused by climate change. The Barangay Balbalasang rainforest is remarkably intact and hosts a high number of species not found anywhere else in the world. The researchers hope that the new discovery can help support conservation efforts to protect the region. Adriane Tobias said: “We dedicate this discovery not only to the unique beauty of the Banao forest but also to the Banao People themselves, who, through their care and stewardship, have ensured the conservation of rare species within these precious forests. It’s rare to find Aeschynanthus in such an environment, and as young botanists, we were thrilled to discover something so distinct.” Dr. Thorogood added: “Many new species remain undocumented in the world’s ‘plant data darkspots’ – up to 15% of the world’s flora in fact. Finding these ‘known unknowns’ is essential for understanding and protecting biodiversity. That’s what makes discoveries such as this one so important for conservation science.” Reference: “Aeschynanthus pentatrichomatus (Gesneriaceae), a new species of lipstick vine from the Banao Protected Landscape of Luzon Island in the Philippines” by Pastor L. Malabrigo, Adriane B. Tobias, Chris J. Thorogood and Jayson A. Mansibang, 12 December 2024, Nordic Journal of Botany. DOI: 10.1111/njb.04580

Researchers have discovered a cellular uptake pathway that is crucial for larger molecules. These molecules can be used to create new drugs for treating cancer and other diseases as they bind in unique ways to their targets and are efficiently taken up by cells. Revolutionary Bitopic Inhibitors Pave the Way for Innovative Disease Treatment Strategies The development of drugs is a balancing act between making sure the drug is a good fit for its target and ensuring it can penetrate the cell membrane to reach that target. Typically, the search for drugs that can cross the cell membrane has focused on small, rigid molecules with nonpolar chemical structures. However, new therapeutic strategies break traditional drug design rules by employing larger, flexibly linked chemical entities. Recently, a team of researchers from the University of California, San Francisco (UCSF) published a study in Science, where they unveiled a new discovery of a cellular uptake pathway that is crucial for larger molecules. These large, complex molecules bind in unique ways to their targets, are efficiently taken up by cells, and have the potential to be used in creating new drugs for the treatment of cancer and other diseases. Through a combination of functional genomics and chemical methods, the scientists uncovered an endogenous pathway involving interferon-induced transmembrane (IFITM) proteins that promote the cellular uptake of diverse linked chemotypes. These proteins are found in plasma membranes and often provide cellular resistance to viruses. Challenges in Traditional Drug Targeting Most traditional pharmaceuticals are small molecules that follow simple molecular rules including limits on the molecular size and number of sticky chemical groups on the molecule’s surface. Many key drug targets, such as kinase enzymes often involved in cancer, are difficult to selectively target with traditional drugs. “There are over 500 human kinase enzymes that are very similar in the pocket where the drug binds, making it a challenge to selectively target a single member of this family and leading to undesirable medication side effects,” explains the study’s first author Kevin Lou. “Increasingly, it has been found that certain linked molecules outside this traditional framework can maintain drug-like properties and gain new mechanisms of action.” There are many important intracellular drug targets that researchers have been unable to target with small, compact, and rigid molecules. To address this challenge, scientists have taken to linking multiple ligands into a single chemical entity (a linked chemotype). These linked chemotypes can have enhanced potency, greater selectivity, and the capacity to induce the association of more than one target. “Given this discrepancy between the favorable biological activity of many large, bivalent molecules and traditional concepts of passive permeability, we inferred that linked chemotypes might hijack cellular processes to assist with passage through the cell membrane,” wrote Lou. We selected as an example a bitopic inhibitor of mTOR, RapaLink-1, whose molecular weight falls well beyond common guidelines.” Designing Multi-Pronged Inhibitors The team designed two new linked drugs that they hypothesized might take advantage of this cellular entry pathway. They generated DasatiLink-1 through a linker-joined combination of two known inhibitors of the leukemia protein BCL-ABL1, known as dasatinib and asciminib. Since each drug binds a distinct pocket on the target protein, the researchers reasoned that the linked version could affix itself to two points of contact like a two-pronged key inserting into two locks, enhancing its specificity and effectiveness. They also designed BisRoc-1 by linking two molecules of the chemotherapy drug rocaglamide together in a way that would allow it to bridge two copies of the drug’s protein target. Despite the fact that both of these drugs violate traditional drug design principles, the team showed that both drugs enter cells, bind tightly to their intended targets, and work just as well as the unlinked versions. The linked versions were uniquely dependent on IFITM protein expression in the target cells, supporting a general role for the IFITM pathway across many types of linked molecules. The researchers showed that DasatiLink-1 is specific for only the BCL-ABL1 kinase, unlike the more relaxed specificity of its two constituent drugs when unlinked. Advantages of Selectivity and Efficiency “Linked inhibitors that require a multi-pronged binding mechanism are much more selective,” Lou explains. “They offer substantial advantages as long as they can enter cells efficiently.” “We discovered that IFITM proteins enable bitopic inhibitors to enter cells and this will likely allow us to target previously untargetable proteins in disease,” said Luke Gilbert, Ph.D., co-corresponding author and the Goldberg-Benioff Endowed Professorship in Prostate Cancer Translational Biology at UCSF. “Hopefully, our study will generate new clues for how IFITM proteins function mechanistically that can be pursued by drug design scientists and virologists.” The scientists are working on chemically optimizing the properties of the linked BCR-ABL inhibitors to increase their potency and position them as next-generation therapeutics for BCR-ABL mutant cancers. “We are also excited to expand the scope of intracellular targets amenable to bitopic inhibition,” said Gilbert. Reference: “IFITM proteins assist cellular uptake of diverse linked chemotypes” by Kevin Lou, Douglas R. Wassarman, Tangpo Yang, YiTing Paung, Ziyang Zhang, Thomas A. O’Loughlin, Megan K. Moore, Regina K. Egan, Patricia Greninger, Cyril H. Benes, Markus A. Seeliger, Jack Taunton, Luke A. Gilbert and Kevan M. Shokat, 8 December 2022, Science. DOI: 10.1126/science.abl5829 The study was funded by the National Institutes of Health, the Damon Runyon Cancer Foundation, the Pew-Stewart Scholars program, the Goldberg-Benioff Endowed Professorship, the Howard Hughes Medical Institute, the Samuel Waxman Cancer Research Foundation, Wellcome Trust, the Ono Pharma Foundation, Pfizer, and Arc Institute.

New research uncovers how human retinas, grown in labs, demonstrate that retinoic acid, rather than thyroid hormones, determines the development of color-sensing cells crucial for human vision. This discovery advances our understanding of color blindness, vision loss, and the genetic basis of how we see color, offering promising avenues for future treatments of vision disorders. Researchers have cultivated human retinas in a laboratory setting, unveiling the process by which a derivative of vitamin A produces the unique cells responsible for humans’ capacity to perceive a vast spectrum of colors. This visual capability is absent in dogs, cats, and various other mammals. “These retinal organoids allowed us for the first time to study this very human-specific trait,” said author Robert Johnston, an associate professor of biology. “It’s a huge question about what makes us human, what makes us different.” The findings, published in PLOS Biology, increase understanding of color blindness, age-related vision loss, and other diseases linked to photoreceptor cells. They also demonstrate how genes instruct the human retina to make specific color-sensing cells, a process scientists thought was controlled by thyroid hormones. Mechanism of Color Sensing By tweaking the cellular properties of the organoids, the research team found that a molecule called retinoic acid determines whether a cone will specialize in sensing red or green light. Only humans with normal vision and closely related primates develop the red sensor. Scientists for decades thought red cones formed through a coin toss mechanism where the cells haphazardly commit to sensing green or red wavelengths—and research from Johnston’s team recently hinted that the process could be controlled by thyroid hormone levels. Instead, the new research suggests red cones materialize through a specific sequence of events orchestrated by retinoic acid within the eye. Retinal organoid marked to show blue cones in cyan and green/red cones in green. Cells called rods that help the eye see in low-light or dark conditions are marked in magenta. Credit: Sarah Hadyniak/Johns Hopkins University The team found that high levels of retinoic acid in early development of the organoids correlated with higher ratios of green cones. Similarly, low levels of the acid changed the retina’s genetic instructions and generated red cones later in development. “There still might be some randomness to it, but our big finding is that you make retinoic acid early in development,” Johnston said. “This timing really matters for learning and understanding how these cone cells are made.” Green and red cone cells are remarkably similar except for a protein called opsin, which detects light and tells the brain what colors people see. Different opsins determine whether a cone will become a green or a red sensor, though the genes of each sensor remain 96% identical. With a breakthrough technique that spotted those subtle genetic differences in the organoids, the team tracked cone ratio changes over 200 days. “Because we can control in organoids the population of green and red cells, we can kind of push the pool to be more green or more red,” said author Sarah Hadyniak, who conducted the research as a doctoral student in Johnston’s lab and is now at Duke University. “That has implications for figuring out exactly how retinoic acid is acting on genes.” Variability and Vision The researchers also mapped the widely varying ratios of these cells in the retinas of 700 adults. Seeing how the green and red cone proportions changed in humans was one of the most surprising findings of the new research, Hadyniak said. A section of a human retina. Dotted lines depict an individual green cone in blue and a red cone in pink. Credit: Sarah Hadyniak/Johns Hopkins University Scientists still don’t fully understand how the ratio of green and red cones can vary so greatly without affecting someone’s vision. If these types of cells determined the length of a human arm, the different ratios would produce “amazingly different” arm lengths, Johnston said. To build an understanding of diseases like macular degeneration, which causes loss of light-sensing cells near the center of the retina, the researchers are working with other Johns Hopkins labs. The goal is to deepen their understanding of how cones and other cells link to the nervous system. “The future hope is to help people with these vision problems,” Johnston said. “It’s going to be a little while before that happens, but just knowing that we can make these different cell types is very, very promising.” Reference: “Retinoic acid signaling regulates spatiotemporal specification of human green and red cones” by Sarah E. Hadyniak, Joanna F. D. Hagen, Kiara C. Eldred, Boris Brenerman, Katarzyna A. Hussey, Rajiv C. McCoy, Michael E. G. Sauria, James A. Kuchenbecker, Thomas Reh, Ian Glass, Maureen Neitz, Jay Neitz, James Taylor and Robert J. Johnston Jr, 11 January 2024, PLOS Biology. DOI: 10.1371/journal.pbio.3002464 Other Johns Hopkins authors include: Kiara C. Eldred, Boris Brenerman, Katarzyna A. Hussey, Joanna F. D. Hagen, Rajiv C. McCoy, Michael E. G. Sauria, and James Taylor; as well as James A. Kuchenbecker, Thomas Reh, Ian Glass, Maureen Neitz, Jay Neitz of the University of Washington.

DVDV1551RTWW78V